ArticleCureus2024
Urothelial Carcinoma With Divergent Glandular Differentiation.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Divergent differentiation in urothelial carcinoma is a challenging phenomenon that often makes the proper histopathological diagnosis a challenge. Conventional foci are often scarce in this subclass of urothelial carcinoma, and even if proper grossing and slide processing is performed, inexperienced pathologists can miss them. Furthermore, divergent differentiation in urothelial carcinoma is important to be recognized as such not only for the true diagnosis to be established and hence not increase the statistical incidence of rare neoplasms but also as divergent differentiation is one of the key factors in defining urothelial carcinomas as high-grade and hence crucial for proper patient management and treatment. Herein, we report a histopathological case of a male patient in his 60s who had been diagnosed with a high-grade urothelial carcinoma with submucosal involvement one year prior. Due to symptom recurrence, a follow-up endoscopy and resection of suspicious areas were performed to check for disease recurrence. Histopathology revealed a malignant neoplasm with histomorphological features of predominantly colonic-type adenocarcinoma and only a few areas with urothelial papillary morphology. Hence, divergent differentiation of the neoplasm was noted. Other than not falsely increasing the incidence of rare bladder malignancies, proper recognition of urothelial divergent differentiation is also important for excluding metastatic lesions to the bladder, as most of the diverging types of differentiation are common in neighboring organs or in tumor types that have pronounced metastatic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.